Achiko AG Announces Annual Results for the Year Ended December 31, 2021
June 26, 2022 19:30 ET
|
Achiko AG
ZURICH, Switzerland, June 26, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended December...
AptameX Production and Commercialization Update
April 28, 2022 08:15 ET
|
Achiko AG
Company has commenced shipping and will book first sales in May 2022Reorganized production line able to meet stronger than expected demand for Achiko AG’s innovative DNA aptamer saliva-based rapid...
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
July 13, 2021 07:30 ET
|
Achiko AG
ZURICH, Switzerland, July 13, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company currently developing technologies that seek to...
Achiko’s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration
April 29, 2021 07:30 ET
|
Achiko AG
Achiko AG’s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution CertificateAchiko Subsequently Commenced Product Registration with its Partners with a View to...